{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T08:58:05Z","timestamp":1790499485011,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,9,16]],"date-time":"2019-09-16T00:00:00Z","timestamp":1568592000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,9,16]],"date-time":"2019-09-16T00:00:00Z","timestamp":1568592000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2019,10,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n              <jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The Copper Metabolism MURR1 (COMM) domain family has been reported to play important roles in tumorigenesis. As a prototype for the COMMD family, the expression pattern and biological function of COMMD6 in human tumours remain unknown.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>COMMD6 expression in BALB\/c mice and human tissues was examined using real-time PCR and immunohistochemistry. Kaplan\u2013Meier analysis was applied to evaluate the prognosis of COMMD6 in tumours. Competing endogenous RNA (ceRNA) and transcriptional regulation network were constructed based on differentially expressed mRNAs, microRNAs and long non-coding RNAs from the cancer genome atlas database. GO and KEGG enrichment analysis were used to explore the bioinformatics implication.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>COMMD6 expression was widely observed in BALB\/c mice and human tissues, which predicted prognosis of cancer patients. Furthermore, we shed light on the underlying tumour promoting role and mechanism of COMMD6 by constructing a TEX41-miR-340-COMMD6 ceRNA network in head and neck squamous cell carcinoma and miR-218-CDX1-COMMD6 transcriptional network in cholangiocarcinoma. In addition, COMMD6 may modulate the ubiquitination and degradation of NF-\u03baB subunits and regulate ribonucleoprotein and spliceosome complex biogenesis in tumours.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This study may help to elucidate the functions and mechanisms of COMMD6 in human tumours, providing a potential biomarker for tumour prevention and therapy.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1038\/s41416-019-0571-x","type":"journal-article","created":{"date-parts":[[2019,9,15]],"date-time":"2019-09-15T23:02:42Z","timestamp":1568588562000},"page":"699-709","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Prognosis and modulation mechanisms of COMMD6 in human tumours based on expression profiling and comprehensive bioinformatics analysis"],"prefix":"10.1038","volume":"121","author":[{"given":"Mi","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqiang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaling","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huazhen","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xixi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longshan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoya","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longhua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,16]]},"reference":[{"key":"571_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A. & Jemal, A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68, 394\u2013424 (2018).","journal-title":"CA Cancer J. Clin."},{"key":"571_CR2","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.stem.2018.11.011","volume":"24","author":"PB Gupta","year":"2019","unstructured":"Gupta, P. B., Pastushenko, I., Skibinski, A., Blanpain, C. & Kuperwasser, C. Phenotypic plasticity: driver of cancer initiation, progression, and therapy resistance. Cell Stem Cell. 24, 65\u201378 (2019).","journal-title":"Cell Stem Cell."},{"key":"571_CR3","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell. 144, 646\u2013674 (2011).","journal-title":"Cell."},{"key":"571_CR4","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1002\/mc.22908","volume":"58","author":"ZQ Zhou","year":"2019","unstructured":"Zhou, Z. Q., Zhao, J. J., Chen, C. L., Liu, Y., Zeng, J. X., Wu, Z. R. et al. HUS1 checkpoint clamp component (HUS1) is a potential tumor suppressor in primary hepatocellular carcinoma. Mol. Carcinog. 58, 76\u201387 (2019).","journal-title":"Mol. Carcinog."},{"key":"571_CR5","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1158\/0008-5472.CAN-14-3595","volume":"76","author":"C Xing","year":"2016","unstructured":"Xing, C., Lu, X. X., Guo, P. D., Shen, T., Zhang, S., He, X. S. et al. Ubiquitin-specific protease 4-mediated deubiquitination and stabilization of PRL-3 is required for potentiating colorectal oncogenesis. Cancer Res. 76, 83\u201395 (2016).","journal-title":"Cancer Res."},{"key":"571_CR6","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1016\/j.bbadis.2013.09.014","volume":"1832","author":"P Bartuzi","year":"2013","unstructured":"Bartuzi, P., Hofker, M. H. & van de Sluis, B. Tuning NF-kappaB activity: a touch of COMMD proteins. Biochim Biophys. Acta. 1832, 2315\u20132321 (2013).","journal-title":"Biochim Biophys. Acta."},{"key":"571_CR7","doi-asserted-by":"publisher","first-page":"251398","DOI":"10.1155\/2013\/251398","volume":"2013","author":"JR Fernandez Masso","year":"2013","unstructured":"Fernandez Masso, J. R., Oliva Arguelles, B., Tejeda, Y., Astrada, S., Garay, H., Reyes, O. et al. The antitumor peptide CIGB-552 increases COMMD1 and inhibits growth of human lung cancer cells. J. Amino Acids. 2013, 251398 (2013).","journal-title":"J. Amino Acids."},{"key":"571_CR8","doi-asserted-by":"publisher","first-page":"5745","DOI":"10.1038\/onc.2017.181","volume":"36","author":"P Mu","year":"2017","unstructured":"Mu, P., Akashi, T., Lu, F., Kishida, S. & Kadomatsu, K. A novel nuclear complex of DRR1, F-actin and COMMD1 involved in NF-kappaB degradation and cell growth suppression in neuroblastoma. Oncogene 36, 5745\u20135756 (2017).","journal-title":"Oncogene"},{"key":"571_CR9","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1172\/JCI40583","volume":"120","author":"B van de Sluis","year":"2010","unstructured":"van de Sluis, B., Mao, X., Zhai, Y., Groot, A. J., Vermeulen, J. F., van der Wall, E. et al. COMMD1 disrupts HIF-1alpha\/beta dimerization and inhibits human tumor cell invasion. J. Clin. Invest. 120, 2119\u20132130 (2010).","journal-title":"J. Clin. Invest."},{"key":"571_CR10","doi-asserted-by":"publisher","first-page":"e0165385","DOI":"10.1371\/journal.pone.0165385","volume":"11","author":"A Fedoseienko","year":"2016","unstructured":"Fedoseienko, A., Wieringa, H. W., Wisman, G. B., Duiker, E., Reyners, A. K., Hofker, M. H. et al. Nuclear COMMD1 is associated with cisplatin sensitivity in ovarian cancer. PLoS ONE 11, e0165385 (2016).","journal-title":"PLoS ONE"},{"key":"571_CR11","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1038\/cdd.2015.147","volume":"23","author":"DW Yeh","year":"2016","unstructured":"Yeh, D. W., Chen, Y. S., Lai, C. Y., Liu, Y. L., Lu, C. H., Lo, J. F. et al. Downregulation of COMMD1 by miR-205 promotes a positive feedback loop for amplifying inflammatory- and stemness-associated properties of cancer cells. Cell Death Differ. 23, 841\u2013852 (2016).","journal-title":"Cell Death Differ."},{"key":"571_CR12","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.omto.2018.12.006","volume":"12","author":"L Zheng","year":"2019","unstructured":"Zheng, L., You, N., Huang, X., Gu, H., Wu, K., Mi, N. et al. COMMD7 regulates NF-kappaB signaling pathway in hepatocellular carcinoma stem-like cells. Mol. Ther. Oncolytics 12, 112\u2013123 (2019).","journal-title":"Mol. Ther. Oncolytics"},{"key":"571_CR13","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.biopha.2017.01.046","volume":"88","author":"N You","year":"2017","unstructured":"You, N., Li, J., Huang, X., Wu, K., Tang, Y., Wang, L. et al. COMMD7 promotes hepatocellular carcinoma through regulating CXCL10. Biomed. Pharmacother. 88, 653\u2013657 (2017).","journal-title":"Biomed. Pharmacother."},{"key":"571_CR14","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1002\/mc.22520","volume":"56","author":"N You","year":"2017","unstructured":"You, N., Li, J., Gong, Z., Huang, X., Wang, W., Wang, L. et al. COMMD7 functions as molecular target in pancreatic ductal adenocarcinoma. Mol. Carcinog. 56, 607\u2013624 (2017).","journal-title":"Mol. Carcinog."},{"key":"571_CR15","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.cellsig.2016.11.016","volume":"30","author":"W Zhan","year":"2017","unstructured":"Zhan, W., Wang, W., Han, T., Xie, C., Zhang, T., Gan, M. et al. COMMD9 promotes TFDP1\/E2F1 transcriptional activity via interaction with TFDP1 in non-small cell lung cancer. Cell Signal. 30, 59\u201366 (2017).","journal-title":"Cell Signal."},{"key":"571_CR16","doi-asserted-by":"publisher","unstructured":"Fan, Y., Zhang, L., Sun, Y., Yang, M., Wang, X., Wu, X. et al. Expression profile and bioinformatics analysis of COMMD10 in BALB\/C mice and human. Cancer Gene Ther. (2019). \n                    https:\/\/doi.org\/10.1038\/s41417-019-0087-9\n                    \n                  . [Epub ahead of print].","DOI":"10.1038\/s41417-019-0087-9"},{"key":"571_CR17","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1038\/bjc.2017.260","volume":"117","author":"SS Yang","year":"2017","unstructured":"Yang, S. S., Li, X. M., Yang, M., Ren, X. L., Hu, J. L., Zhu, X. H. et al. FMNL2 destabilises COMMD10 to activate NF-kappaB pathway in invasion and metastasis of colorectal cancer. Br. J. Cancer 117, 1164\u20131175 (2017).","journal-title":"Br. J. Cancer"},{"key":"571_CR18","doi-asserted-by":"publisher","first-page":"22222","DOI":"10.1074\/jbc.M501928200","volume":"280","author":"E Burstein","year":"2005","unstructured":"Burstein, E., Hoberg, J. E., Wilkinson, A. S., Rumble, J. M., Csomos, R. A., Komarck, C. M. et al. COMMD proteins, a novel family of structural and functional homologs of MURR1. J. Biol. Chem. 280, 22222\u201322232 (2005).","journal-title":"J. Biol. Chem."},{"key":"571_CR19","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1016\/j.biocel.2009.07.007","volume":"41","author":"P Li","year":"2009","unstructured":"Li, P., Zhang, S. & Fan, C. COMMD6 from amphioxus Branchiostoma belcheri (BbCOMMD6) interacts with creatine kinase and inhibits its activity. Int. J. Biochem. Cell Biol. 41, 2459\u20132465 (2009).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"571_CR20","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1161\/CIRCRESAHA.117.312004","volume":"122","author":"A Fedoseienko","year":"2018","unstructured":"Fedoseienko, A., Wijers, M., Wolters, J. C., Dekker, D., Smit, M., Huijkman, N. et al. The COMMD family regulates plasma LDL levels and attenuates atherosclerosis through stabilizing the CCC complex in endosomal LDLR trafficking. Circ. Res. 122, 1648\u20131660 (2018).","journal-title":"Circ. Res."},{"key":"571_CR21","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1042\/BJ20051664","volume":"398","author":"P de Bie","year":"2006","unstructured":"de Bie, P., van de Sluis, B., Burstein, E., Duran, K. J., Berger, R., Duckett, C. S. et al. Characterization of COMMD protein-protein interactions in NF-kappaB signalling. Biochem. J. 398, 63\u201371 (2006).","journal-title":"Biochem. J."},{"key":"571_CR22","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.molmed.2015.04.001","volume":"21","author":"K Shostak","year":"2015","unstructured":"Shostak, K. & Chariot, A. EGFR and NF-kappaB: partners in cancer. Trends Mol. Med. 21, 385\u2013393 (2015).","journal-title":"Trends Mol. Med."},{"key":"571_CR23","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1093\/molbev\/msy096","volume":"35","author":"S Kumar","year":"2018","unstructured":"Kumar, S., Stecher, G., Li, M., Knyaz, C. & Tamura, K. MEGA X: molecular evolutionary genetics analysis across computing platforms. Mol. Biol. Evol. 35, 1547\u20131549 (2018).","journal-title":"Mol. Biol. Evol."},{"key":"571_CR24","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1136\/jmedgenet-2015-103334","volume":"52","author":"X Qi","year":"2015","unstructured":"Qi, X., Zhang, D. H., Wu, N., Xiao, J. H., Wang, X. & Ma, W. ceRNA in cancer: possible functions and clinical implications. J Med Genet. 52, 710\u2013718 (2015).","journal-title":"J Med Genet."},{"key":"571_CR25","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1042\/EBC20180067","volume":"63","author":"TO Tolsma","year":"2019","unstructured":"Tolsma, T. O. & Hansen, J. C. Post-translational modifications and chromatin dynamics. Essays Biochem. 63, 89\u201396 (2019).","journal-title":"Essays Biochem."},{"key":"571_CR26","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.gene.2018.06.062","volume":"675","author":"Y Qin","year":"2018","unstructured":"Qin, Y., Zhou, X., Huang, C., Li, L., Liu, H., Liang, N. et al. Lower miR-340 expression predicts poor prognosis of non-small cell lung cancer and promotes cell proliferation by targeting CDK4. Gene 675, 278\u2013284 (2018).","journal-title":"Gene"},{"key":"571_CR27","first-page":"2875","volume":"21","author":"LL Zhang","year":"2017","unstructured":"Zhang, L. L., Xie, F. J., Tang, C. H., Xu, W. R., Ding, X. S. & Liang, J. miR-340 suppresses tumor growth and enhances chemosensitivity of colorectal cancer by targeting RLIP76. Eur. Rev. Med. Pharmacol. Sci. 21, 2875\u20132886 (2017).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"9","key":"571_CR28","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1002\/cbin.10974","volume":"42","author":"Hemei Xiao","year":"2018","unstructured":"Xiao, H., Yu, L., Li, F., Wang, H., Li, W., He, X. MiR-340 suppresses the metastasis by targeting EphA3 in cervical cancer. Cell Biol. Int. 42 1115\u20131123 (2018). \n                    https:\/\/doi.org\/10.1002\/cbin.10974\n                    \n                  . Epub 2018 Jul 11.","journal-title":"Cell Biology International"},{"key":"571_CR29","first-page":"982","volume":"23","author":"S Rongxin","year":"2019","unstructured":"Rongxin, S., Pengfei, L., Li, S., Xiaochen, J. & Yihe, H. MicroRNA-340-5p suppresses osteosarcoma development by down-regulating the Wnt\/beta-catenin signaling pathway via targeting the STAT3 gene. Eur. Rev. Med. Pharmacol. Sci. 23, 982\u2013991 (2019).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"571_CR30","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1158\/0008-5472.CAN-14-0938","volume":"75","author":"D Yamashita","year":"2015","unstructured":"Yamashita, D., Kondo, T., Ohue, S., Takahashi, H., Ishikawa, M., Matoba, R. et al. miR340 suppresses the stem-like cell function of glioma-initiating cells by targeting tissue plasminogen activator. Cancer Res. 75, 1123\u20131133 (2015).","journal-title":"Cancer Res."},{"key":"571_CR31","first-page":"6242173","volume":"2018","author":"W Li","year":"2018","unstructured":"Li, W., Qi, Y., Cui, X., Huo, Q., Zhu, L., Zhang, A. et al. Characteristic of HPV integration in the genome and transcriptome of cervical cancer tissues. Biomed. Res. Int. 2018, 6242173 (2018).","journal-title":"Biomed. Res. Int."},{"key":"571_CR32","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.gene.2017.03.022","volume":"615","author":"X Zhang","year":"2017","unstructured":"Zhang, X., Dong, J., He, Y., Zhao, M., Liu, Z., Wang, N. et al. miR-218 inhibited tumor angiogenesis by targeting ROBO1 in gastric cancer. Gene 615, 42\u201349 (2017).","journal-title":"Gene"},{"key":"571_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-017-0710-z","volume":"16","author":"Y Yang","year":"2017","unstructured":"Yang, Y., Ding, L., Hu, Q., Xia, J., Sun, J., Wang, X. et al. MicroRNA-218 functions as a tumor suppressor in lung cancer by targeting IL-6\/STAT3 and negatively correlates with poor prognosis. Mol. Cancer. 16, 141 (2017).","journal-title":"Mol. Cancer."},{"key":"571_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-0981-7","volume":"18","author":"T Liu","year":"2019","unstructured":"Liu, T., Zhang, X., Du, L., Wang, Y., Liu, X., Tian, H. et al. Exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant colorectal cancer. Mol. Cancer. 18, 43 (2019).","journal-title":"Mol. Cancer."},{"key":"571_CR35","first-page":"4039","volume":"7","author":"ZD Xiao","year":"2014","unstructured":"Xiao, Z. D., Jiao, C. Y., Huang, H. T., He, L. J., Zhao, J. J., Lu, Z. Y. et al. miR-218 modulate hepatocellular carcinoma cell proliferation through PTEN\/AKT\/PI3K pathway and HoxA10. Int. J. Clin. Exp. Pathol. 7, 4039\u20134044 (2014).","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"571_CR36","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1007\/s13277-014-2679-1","volume":"36","author":"C Sui","year":"2015","unstructured":"Sui, C., Xu, F., Shen, W., Geng, L., Xie, F., Dai, B. et al. Overexpression of miR-218 inhibits hepatocellular carcinoma cell growth through RET. Tumour Biol. 36, 1511\u20131518 (2015).","journal-title":"Tumour Biol."},{"key":"571_CR37","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1093\/abbs\/gmx017","volume":"49","author":"T Wang","year":"2017","unstructured":"Wang, T., Xu, L., Jia, R. & Wei, J. MiR-218 suppresses the metastasis and EMT of HCC cells via targeting SERBP1. Acta Biochim Biophys. Sin. (Shanghai). 49, 383\u2013391 (2017).","journal-title":"Acta Biochim Biophys. Sin. (Shanghai)."},{"key":"571_CR38","doi-asserted-by":"publisher","first-page":"647","DOI":"10.3346\/jkms.2011.26.5.647","volume":"26","author":"JM Kang","year":"2011","unstructured":"Kang, J. M., Lee, B. H., Kim, N., Lee, H. S., Lee, H. E., Park, J. H. et al. CDX1 and CDX2 expression in intestinal metaplasia, dysplasia and gastric cancer. J. Korean Med. Sci. 26, 647\u2013653 (2011).","journal-title":"J. Korean Med. Sci."},{"key":"571_CR39","doi-asserted-by":"publisher","first-page":"E1550","DOI":"10.1073\/pnas.1503370112","volume":"112","author":"MF Jones","year":"2015","unstructured":"Jones, M. F., Hara, T., Francis, P., Li, X. L., Bilke, S., Zhu, Y. et al. The CDX1-microRNA-215 axis regulates colorectal cancer stem cell differentiation. Proc. Natl Acad. Sci. USA 112, E1550\u2013E1558 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"571_CR40","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/j.bbrc.2018.03.104","volume":"498","author":"R Zheng","year":"2018","unstructured":"Zheng, R., Lin, S., Guan, L., Yuan, H., Liu, K., Liu, C. et al. Long non-coding RNA XIST inhibited breast cancer cell growth, migration, and invasion via miR-155\/CDX1 axis. Biochem. Biophys. Res. Commun. 498, 1002\u20131008 (2018).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"571_CR41","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.suronc.2016.05.026","volume":"25","author":"H Zheng","year":"2016","unstructured":"Zheng, H., Yang, Y., Wang, M. C., Yuan, S. X., Tian, T., Han, J. et al. Low CDX1 expression predicts a poor prognosis for hepatocellular carcinoma patients after hepatectomy. Surg. Oncol. 25, 171\u2013177 (2016).","journal-title":"Surg. Oncol."},{"key":"571_CR42","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1002\/jcb.26151","volume":"119","author":"M Riera-Romo","year":"2018","unstructured":"Riera-Romo, M. COMMD1: a multifunctional regulatory protein. J. Cell Biochem. 119, 34\u201351 (2018).","journal-title":"J. Cell Biochem."},{"key":"571_CR43","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1158\/0008-5472.CAN-09-1397","volume":"70","author":"HC Thoms","year":"2010","unstructured":"Thoms, H. C., Loveridge, C. J., Simpson, J., Clipson, A., Reinhardt, K., Dunlop, M. G. et al. Nucleolar targeting of RelA(p65) is regulated by COMMD1-dependent ubiquitination. Cancer Res. 70, 139\u2013149 (2010).","journal-title":"Cancer Res."},{"key":"571_CR44","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/embor.2009.10","volume":"10","author":"H Geng","year":"2009","unstructured":"Geng, H., Wittwer, T., Dittrich-Breiholz, O., Kracht, M. & Schmitz, M. L. Phosphorylation of NF-kappaB p65 at Ser468 controls its COMMD1-dependent ubiquitination and target gene-specific proteasomal elimination. EMBO Rep. 10, 381\u2013386 (2009).","journal-title":"EMBO Rep."},{"key":"571_CR45","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1172\/JCI66466","volume":"123","author":"P Starokadomskyy","year":"2013","unstructured":"Starokadomskyy, P., Gluck, N., Li, H., Chen, B., Wallis, M., Maine, G. N. et al. CCDC22 deficiency in humans blunts activation of proinflammatory NF-kappaB signaling. J. Clin. Invest. 123, 2244\u20132256 (2013).","journal-title":"J. Clin. Invest."},{"key":"571_CR46","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/ng.2508","volume":"45","author":"K De Keersmaecker","year":"2013","unstructured":"De Keersmaecker, K., Atak, Z. K., Li, N., Vicente, C., Patchett, S., Girardi, T. et al. Exome sequencing identifies mutation in CNOT3 and ribosomal genes RPL5 and RPL10 in T-cell acute lymphoblastic leukemia. Nat. Genet. 45, 186\u2013190 (2013).","journal-title":"Nat. Genet."},{"key":"571_CR47","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1053\/j.gastro.2014.06.009","volume":"147","author":"TT Nieminen","year":"2014","unstructured":"Nieminen, T. T., O\u2019Donohue, M. F., Wu, Y., Lohi, H., Scherer, S. W., Paterson, A. D. et al. Germline mutation of RPS20, encoding a ribosomal protein, causes predisposition to hereditary nonpolyposis colorectal carcinoma without DNA mismatch repair deficiency. Gastroenterology. 147, 595\u2013598 e5 (2014).","journal-title":"Gastroenterology."},{"key":"571_CR48","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.ygyno.2012.10.026","volume":"128","author":"AP Novetsky","year":"2013","unstructured":"Novetsky, A. P., Zighelboim, I., Thompson, D. M. Jr, Powell, M. A., Mutch, D. G. & Goodfellow, P. J. Frequent mutations in the RPL22 gene and its clinical and functional implications. Gynecol. Oncol. 128, 470\u2013474 (2013).","journal-title":"Gynecol. Oncol."},{"key":"571_CR49","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/nature14985","volume":"525","author":"TY Hsu","year":"2015","unstructured":"Hsu, T. Y., Simon, L. M., Neill, N. J., Marcotte, R., Sayad, A., Bland, C. S. et al. The spliceosome is a therapeutic vulnerability in MYC-driven cancer. Nature. 525, 384\u2013388 (2015).","journal-title":"Nature."}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41416-019-0571-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41416-019-0571-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41416-019-0571-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:05:43Z","timestamp":1684616743000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-019-0571-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,16]]},"references-count":49,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,10,15]]}},"alternative-id":["571"],"URL":"https:\/\/doi.org\/10.1038\/s41416-019-0571-x","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,16]]},"assertion":[{"value":"11 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Ethics Committee of Nanfang Hospital of Southern Medical University, and all participants provided written informed consent prior to surgery. The study conforms to the provisions of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"This project was supported by the National Natural Science Foundation of China (NO. 81602685, 81672992); the Science and Technology Projects in Guangdong Province (NO. 2018-1201-SF-0019); and the Natural Science Foundation of Guangdong Province (NO. 2017A030313486).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"All the analysis data were obtained from TCGA database ().","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}}]}}